Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Sam King's 9-year-old son was diagnosed with Type 1 diabetes.King, who is now an associate professor of computer science at ...

Chloe and Caleb have grown up at the Alberta Children’s Hospital. Even though the twins live with different conditions, the ...

The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous ...

Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024. "Building on our ...

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Today, the U.S. Food and Drug Administration is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing ...

The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...

Patients trying to access technology for type one diabetes say they are not getting the support they need. Patients say ...

Dr Hamish Crocket, Senior Lecturer at the University of Waikato’s School of Health Equity and Innovation, will co-lead the $1 ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Executive Editor David ...